Our previous study indicated that MALAT-1 may serve as an oncogenic lncRNA that is involved in malignancy phenotypes of pancreatic cancer, and revealed that MALAT-1 knockdown could suppress EMT process and decrease the protein expression of cancer stem-like cell markers including CD44, CD24 and ALDH [13]. Here, MALAT1 is linked to pancreatic neoplasm.